Clinical Trial Update: Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated adjunctive systemic moxifloxacin for aggressive periodontitis, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Periodontitis

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Facultad Nacional de Salud Publica | Conditions: Aggressive Periodontitis | Phase 4 | Status: COMPLETED